Loring Wolcott & Coolidge Fiduciary Advisors’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $470K | Hold |
1,205
| – | – | ﹤0.01% | 238 |
|
|
2026
Q1 | $597K | Hold |
1,205
| – | – | 0.01% | 216 |
|
|
2025
Q4 | $610K | Hold |
1,205
| – | – | 0.01% | 220 |
|
|
2025
Q3 | $530K | Buy |
1,205
+1,005
| +503% | +$390K | ﹤0.01% | 238 |
|
|
2025
Q2 | $76.6K | Sell |
200
-300
| -60% | -$108K | ﹤0.01% | 365 |
|
|
2025
Q1 | $168K | Hold |
500
| – | – | ﹤0.01% | 285 |
|
|
2024
Q4 | $166K | Hold |
500
| – | – | ﹤0.01% | 302 |
|
|
2024
Q3 | $199K | Hold |
500
| – | – | ﹤0.01% | 282 |
|
|
2024
Q2 | $159K | Hold |
500
| – | – | ﹤0.01% | 293 |
|
|
2024
Q1 | $155K | Hold |
500
| – | – | ﹤0.01% | 294 |
|
|
2023
Q4 | $152K | Hold |
500
| – | – | ﹤0.01% | 302 |
|
|
2023
Q3 | $114K | Sell |
500
-500
| -50% | -$137K | ﹤0.01% | 338 |
|
|
2023
Q2 | $303K | Hold |
1,000
| – | – | ﹤0.01% | 247 |
|
|
2023
Q1 | $264K | Hold |
1,000
| – | – | ﹤0.01% | 252 |
|
|
2022
Q4 | $240K | Sell |
1,000
-48
| -5% | -$10.8K | ﹤0.01% | 261 |
|
|
2022
Q3 | $193K | Hold |
1,048
| – | – | ﹤0.01% | 285 |
|
|
2022
Q2 | $176K | Buy |
1,048
+48
| +5% | +$10.3K | ﹤0.01% | 304 |
|
|
2022
Q1 | $251K | Sell |
1,000
-65
| -6% | -$16.3K | ﹤0.01% | 280 |
|
|
2021
Q4 | $274K | Hold |
1,065
| – | – | ﹤0.01% | 273 |
|
|
2021
Q3 | $258K | Buy |
1,065
+25
| +2% | +$6.11K | ﹤0.01% | 277 |
|
|
2021
Q2 | $215K | Buy |
+1,040
| New | +$212K | ﹤0.01% | 308 |
|
|
2021
Q1 | – | Sell |
-1,000
| Closed | -$164K | – | 475 |
|
|
2020
Q4 | $164K | Hold |
1,000
| – | – | ﹤0.01% | 295 |
|
|
2020
Q3 | $125K | Hold |
1,000
| – | – | ﹤0.01% | 302 |
|
|
2020
Q2 | $97K | Hold |
1,000
| – | – | ﹤0.01% | 312 |
|
|
2020
Q1 | $90K | Hold |
1,000
| – | – | ﹤0.01% | 305 |
|
|
2019
Q4 | $148K | Sell |
1,000
-34
| -3% | -$4.57K | ﹤0.01% | 300 |
|
|
2019
Q3 | $125K | Sell |
1,034
-45
| -4% | -$5.82K | ﹤0.01% | 308 |
|
|
2019
Q2 | $146K | Buy |
1,079
+45
| +4% | +$5.69K | ﹤0.01% | 293 |
|
|
2019
Q1 | $135K | Hold |
1,034
| – | – | ﹤0.01% | 294 |
|
|
2018
Q4 | $129K | Hold |
1,034
| – | – | ﹤0.01% | 294 |
|
|
2018
Q3 | $144K | Hold |
1,034
| – | – | ﹤0.01% | 304 |
|
|
2018
Q2 | $106K | Hold |
1,034
| – | – | ﹤0.01% | 348 |
|
|
2018
Q1 | $100K | Hold |
1,034
| – | – | ﹤0.01% | 363 |
|
|
2017
Q4 | $91K | Hold |
1,034
| – | – | ﹤0.01% | 371 |
|
|
2017
Q3 | $82K | Buy |
1,034
+34
| +3% | +$2.73K | ﹤0.01% | 378 |
|
|
2017
Q2 | $80K | Hold |
1,000
| – | – | ﹤0.01% | 376 |
|
|
2017
Q1 | $89K | Buy |
+1,000
| New | +$83.4K | ﹤0.01% | 364 |
|
Other funds holding HCA
MC
CCP
Loring Wolcott & Coolidge Fiduciary Advisors's HCA Position: Q2 2026 in Review
Loring Wolcott & Coolidge Fiduciary Advisors held its HCA Healthcare (HCA) position steady in Q2 2026 at 1,205 shares worth $470K. The position accounts for ﹤0.01% of the portfolio, ranked #238.
Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in HCA in Q1 2017 and has held it in 37 quarters since. The position peaked at $610K in Q4 2025. 750 funds tracked by Wall St. Rank hold HCA as of Q2 2026.
- Loring Wolcott & Coolidge Fiduciary Advisors held 1,205 shares of HCA Healthcare worth $470K as of Q2 2026.
- Loring Wolcott & Coolidge Fiduciary Advisors left its HCA Healthcare share count unchanged in Q2 2026.
- HCA Healthcare made up ﹤0.01% of Loring Wolcott & Coolidge Fiduciary Advisors's portfolio in Q2 2026, its #238 holding.
- Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in HCA Healthcare in Q1 2017 and has held it in 37 quarters since.
- Loring Wolcott & Coolidge Fiduciary Advisors's HCA Healthcare position peaked at $610K in Q4 2025.
- 750 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.
Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.